Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07583563 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

StatusRecruiting
PhaseNot specified
SponsorCamurus AB
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 2 of 9 entries
    • Site details revised at 2 of 6 sites
    • Eligibility criteria expanded, about 3 words
  2. Study sites: 5 to 6v5
  3. Study sites: 4 to 5v4
  4. Recruitment opened
    • Start date changed from estimate of Jun 2026 to Jun 5, 2026
    • Site details revised at 4 of 4 sites
    v3
  5. Trial sites expanded: 0 → 4 locations
    • Primary and study completion pushed from May 2029 to Jun 2029
    • Start date: May 2026 to Jun 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Camurus AB
4 trials monitored
See 1 trial at risk
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Trial Details
NCT Number NCT07583563
Lead Sponsor Camurus AB
Conditions
(from sponsor)		 Acromegaly
Related terms Acromegaly
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov